Psychedelic therapy: does trip intensity matter?
NCT ID NCT07164287
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at 376 patients who received psychedelic-assisted therapy with LSD or psilocybin for depression, anxiety, PTSD, or substance use disorders. Researchers want to see if the intensity of the psychedelic experience is linked to better outcomes. All data comes from past clinical records at a Swiss hospital.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LSD or psilocybin
- What this could lead to
- If successful, this could help doctors understand how the intensity of a psychedelic session influences mental health outcomes, potentially guiding better treatment plans.
- What could go wrong
- This is a retrospective study, meaning it looks at past data, not a controlled experiment. Results may be less reliable and cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Geneva University Hospital
Geneva, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Middle school jitters: a new program aims to smooth the transition for anxious students
- Can your Child's doctor treat anxiety? a new approach puts it to the test
- Faith-Based therapy aims to heal trauma in young women
- Can ancient breathing techniques rewire the depressed teen brain?
- Could play be a lifeline for children of war? a major study investigates
- Can breathing exercises help veterans heal from trauma and addiction?